Congenital von Willebrand disease type I: definition, phenotypes, clinical and laboratory assessment

被引:32
作者
Rodeghiero, F [1 ]
Castaman, G
机构
[1] San Bortolo Hosp, Dept Hematol, I-36100 Vicenza, Italy
[2] San Bortolo Hosp, Hemophilia & Thrombosis Ctr, I-36100 Vicenza, Italy
关键词
von Willebrand factor; von Willebrand disease; inherited bleeding disorder; gene mutation;
D O I
10.1053/beha.2001.0136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Von Willebrand disease, with a prevalence of about 1% in the general population, is the most frequent inherited bleeding disorder. Among the major subtypes, type I von Willebrand disease represents by far the more prevalent category (about 70%) and includes cases with a partial deficiency of plasma von Willebrand factor and no evidence of qualitative defects. The clinical expression as well as the laboratory phenotype of the disorder and its penetrance are greatly variable. The diagnosis usually requires the presence of autosomally inherited bleeding history co-segregating with a low von Willebrand factor level. The influence of several genetic and acquired conditions on the level of von Willebrand factor is however, widely appreciated and represents the major obstacle in correctly identifying von Willebrand disease as the cause of a bleeding diathesis in several families. The molecular genetics of the minority of cases showing high penetrance and expressivity of the phenotype are unravelling, but for the large majority of milder cases, the molecular basis is still unknown. We present a practical approach to diagnosis, based on scientific evidence and direct experience. The implications of the diagnosis of von Willebrand disease for the patient's quality of life are also considered.
引用
收藏
页码:321 / 335
页数:15
相关论文
共 60 条
[41]  
NICHOLS WC, 1994, BLOOD, V83, P3225
[42]  
NIEUWENHUIS HK, 1987, BLOOD, V70, P620
[43]  
NILLSON IM, 1984, SCAND J HAEMATOL S40, V33, P21
[44]  
ORSTAVIK KH, 1985, AM J HUM GENET, V37, P89
[45]   VONWILLEBRAND DISEASE TYPE-B - A MISSENSE MUTATION SELECTIVELY ABOLISHES RISTOCETIN-INDUCED VONWILLEBRAND-FACTOR BINDING TO PLATELET GLYCOPROTEIN-IB [J].
RABINOWITZ, I ;
TULEY, EA ;
MANCUSO, DJ ;
RANDI, AM ;
FIRKIN, BG ;
HOWARD, MA ;
SADLER, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (20) :9846-9849
[46]  
RODEGHIERO F, 1990, THROMB HAEMOSTASIS, V64, P349
[47]   REPLACEMENT THERAPY WITH VIRUS-INACTIVATED PLASMA CONCENTRATES IN VONWILLEBRAND DISEASE [J].
RODEGHIERO, F ;
CASTAMAN, G ;
MEYER, D ;
MANNUCCI, PM .
VOX SANGUINIS, 1992, 62 (04) :193-199
[48]  
RODEGHIERO F, 1987, BLOOD, V69, P454
[49]  
RODEGHIERO F, 1990, RES CLIN LAB, V20, P143
[50]   VARIANT VONWILLEBRANDS DISEASE - CHARACTERIZATION OF 2 SUBTYPES BY ANALYSIS OF MULTIMERIC COMPOSITION OF FACTOR 8 VONWILLEBRAND-FACTOR IN PLASMA AND PLATELETS [J].
RUGGERI, ZM ;
ZIMMERMAN, TS .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (06) :1318-1325